Bullfrog AI (BFRG) Competitors

Bullfrog AI logo
$3.21 +0.19 (+6.26%)
As of 03:16 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BFRG vs. ZIVO, KPTI, RANI, IMAB, ASRT, GALT, ANL, EPIX, AVTE, and ENTX

Should you be buying Bullfrog AI stock or one of its competitors? The main competitors of Bullfrog AI include ZIVO Bioscience (ZIVO), Karyopharm Therapeutics (KPTI), Rani Therapeutics (RANI), I-Mab (IMAB), Assertio (ASRT), Galectin Therapeutics (GALT), Adlai Nortye (ANL), ESSA Pharma (EPIX), Aerovate Therapeutics (AVTE), and Entera Bio (ENTX). These companies are all part of the "pharmaceutical products" industry.

Bullfrog AI vs.

ZIVO Bioscience (NASDAQ:ZIVO) and Bullfrog AI (NASDAQ:BFRG) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, community ranking, analyst recommendations, earnings and valuation.

12.8% of ZIVO Bioscience shares are held by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are held by institutional investors. 21.5% of ZIVO Bioscience shares are held by insiders. Comparatively, 33.9% of Bullfrog AI shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Bullfrog AI had 3 more articles in the media than ZIVO Bioscience. MarketBeat recorded 4 mentions for Bullfrog AI and 1 mentions for ZIVO Bioscience. ZIVO Bioscience's average media sentiment score of 0.00 equaled Bullfrog AI'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ZIVO Bioscience
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Bullfrog AI
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Bullfrog AI has higher revenue and earnings than ZIVO Bioscience. ZIVO Bioscience is trading at a lower price-to-earnings ratio than Bullfrog AI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ZIVO Bioscience$15.85K4,903.45-$7.78M-$4.88-4.30
Bullfrog AI$60K490.66-$5.36M-$0.85-3.98

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ZIVO Bioscience
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Bullfrog AI
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

ZIVO Bioscience's return on equity of 0.00% beat Bullfrog AI's return on equity.

Company Net Margins Return on Equity Return on Assets
ZIVO BioscienceN/A N/A -2,240.92%
Bullfrog AI N/A -141.39%-124.63%

ZIVO Bioscience has a beta of 0.12, indicating that its share price is 88% less volatile than the S&P 500. Comparatively, Bullfrog AI has a beta of 0.18, indicating that its share price is 82% less volatile than the S&P 500.

ZIVO Bioscience received 99 more outperform votes than Bullfrog AI when rated by MarketBeat users.

CompanyUnderperformOutperform
ZIVO BioscienceOutperform Votes
99
60.74%
Underperform Votes
64
39.26%
Bullfrog AIN/AN/A

Summary

Bullfrog AI beats ZIVO Bioscience on 8 of the 13 factors compared between the two stocks.

Get Bullfrog AI News Delivered to You Automatically

Sign up to receive the latest news and ratings for BFRG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BFRG vs. The Competition

MetricBullfrog AIPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$29.57M$6.89B$5.69B$9.01B
Dividend YieldN/A2.91%5.32%4.00%
P/E Ratio-3.999.0588.1319.30
Price / Sales490.66306.801,013.7874.83
Price / CashN/A75.4646.0938.87
Price / Book7.865.495.054.98
Net Income-$5.36M$123.50M$113.45M$222.75M
7 Day Performance37.40%-4.93%-1.68%-0.94%
1 Month Performance59.43%-2.49%3.13%2.50%
1 Year Performance-28.24%1.42%20.86%17.53%

Bullfrog AI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BFRG
Bullfrog AI
0.0675 of 5 stars
$3.21
+6.3%
N/A-39.7%$27.36M$60,000.00-3.704Short Interest ↑
News Coverage
Gap Down
ZIVO
ZIVO Bioscience
N/A$21.24
+7.3%
N/A+139.4%$78.80M$30,000.00-4.3510
KPTI
Karyopharm Therapeutics
3.8227 of 5 stars
$0.62
flat
$5.00
+703.7%
-55.4%$78.50M$146.03M-0.55380Analyst Forecast
RANI
Rani Therapeutics
3.5732 of 5 stars
$1.36
-2.2%
$11.71
+761.3%
-62.8%$77.91MN/A-1.28110Gap Up
IMAB
I-Mab
3.5266 of 5 stars
$0.95
-6.8%
$8.00
+741.1%
-43.9%$77.52M$3.27M0.00380Short Interest ↓
ASRT
Assertio
3.4176 of 5 stars
$0.81
+0.9%
$3.25
+301.2%
+7.1%$77.34M$125.76M-1.1120Short Interest ↓
Positive News
GALT
Galectin Therapeutics
1.9353 of 5 stars
$1.23
-1.6%
$11.00
+794.3%
-22.5%$77.20MN/A-1.689
ANL
Adlai Nortye
1.9193 of 5 stars
$2.09
-1.4%
$9.00
+330.6%
-74.2%$77.12M$5M0.00127Short Interest ↑
EPIX
ESSA Pharma
3.3422 of 5 stars
$1.69
-1.7%
$9.50
+462.1%
-84.6%$75.02MN/A-2.6450Earnings Report
AVTE
Aerovate Therapeutics
0.4518 of 5 stars
$2.59
-1.1%
$2.25
-13.1%
-88.5%$74.80MN/A-0.8720Short Interest ↑
ENTX
Entera Bio
3.1359 of 5 stars
$2.09
-4.6%
$10.00
+378.5%
+163.3%$74.78M$130,000.00-8.0420Short Interest ↓
Positive News

Related Companies and Tools


This page (NASDAQ:BFRG) was last updated on 2/12/2025 by MarketBeat.com Staff
From Our Partners